SG10201601086WA - Cardiovascular therapeutics - Google Patents
Cardiovascular therapeuticsInfo
- Publication number
- SG10201601086WA SG10201601086WA SG10201601086WA SG10201601086WA SG10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA
- Authority
- SG
- Singapore
- Prior art keywords
- cardiovascular therapeutics
- therapeutics
- cardiovascular
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161525140P | 2011-08-18 | 2011-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201601086WA true SG10201601086WA (en) | 2016-03-30 |
Family
ID=47715527
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201601086WA SG10201601086WA (en) | 2011-08-18 | 2012-08-17 | Cardiovascular therapeutics |
| SG11201400067TA SG11201400067TA (en) | 2011-08-18 | 2012-08-17 | Cardiovascular therapeutics |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400067TA SG11201400067TA (en) | 2011-08-18 | 2012-08-17 | Cardiovascular therapeutics |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9783574B2 (https=) |
| EP (1) | EP2744506B1 (https=) |
| JP (1) | JP6222779B2 (https=) |
| CN (1) | CN103889438B (https=) |
| AU (1) | AU2012296266B2 (https=) |
| CA (1) | CA2845617A1 (https=) |
| SG (2) | SG10201601086WA (https=) |
| WO (1) | WO2013024362A2 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155590A (en) | 1962-08-02 | 1964-11-03 | Ncr Co | Encapsulation process and its product |
| US3488418A (en) | 1965-11-18 | 1970-01-06 | Sterling Drug Inc | Sustained relief analgesic composition |
| US3391416A (en) | 1966-07-14 | 1968-07-09 | Wollard Aircraft Service Equip | Conveyance loader system |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| JP4181232B2 (ja) | 1997-07-18 | 2008-11-12 | 帝國製薬株式会社 | ジクロフェナクナトリウム含有油性外用貼付製剤 |
| US6193996B1 (en) | 1998-04-02 | 2001-02-27 | 3M Innovative Properties Company | Device for the transdermal delivery of diclofenac |
| US6410041B1 (en) | 1998-04-28 | 2002-06-25 | Trustees Of Tufts College | Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine |
| WO2000018352A2 (en) | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | A method for treating inflammatory diseases by administering a thrombin inhibitor |
| US20050171021A1 (en) * | 1998-11-12 | 2005-08-04 | Cormier Michel J. | Buffered drug formulations for transdermal |
| US6309380B1 (en) | 1999-01-27 | 2001-10-30 | Marian L. Larson | Drug delivery via conformal film |
| GB9917165D0 (en) * | 1999-07-22 | 1999-09-22 | Knoll Ag | Polypeptides polynuclcotides and uses thereof |
| US6273831B1 (en) * | 1999-09-03 | 2001-08-14 | Callaway Golf Company | Golf club head with a polymer insert |
| WO2005052593A1 (en) * | 2003-10-29 | 2005-06-09 | The University Of Leicester | Detection |
| CA2554599A1 (en) * | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel brain natriuretic peptide variants and methods of use thereof |
| WO2008030122A1 (en) * | 2006-09-07 | 2008-03-13 | University Of Otago | Biomarkers |
-
2012
- 2012-08-17 AU AU2012296266A patent/AU2012296266B2/en not_active Ceased
- 2012-08-17 EP EP12823283.2A patent/EP2744506B1/en active Active
- 2012-08-17 CN CN201280050843.1A patent/CN103889438B/zh not_active Expired - Fee Related
- 2012-08-17 CA CA2845617A patent/CA2845617A1/en not_active Abandoned
- 2012-08-17 SG SG10201601086WA patent/SG10201601086WA/en unknown
- 2012-08-17 WO PCT/IB2012/002117 patent/WO2013024362A2/en not_active Ceased
- 2012-08-17 US US13/589,082 patent/US9783574B2/en not_active Expired - Fee Related
- 2012-08-17 JP JP2014525515A patent/JP6222779B2/ja not_active Expired - Fee Related
- 2012-08-17 SG SG11201400067TA patent/SG11201400067TA/en unknown
-
2017
- 2017-09-05 US US15/695,876 patent/US20180148475A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ621790A (en) | 2017-09-29 |
| EP2744506A2 (en) | 2014-06-25 |
| WO2013024362A2 (en) | 2013-02-21 |
| US20180148475A1 (en) | 2018-05-31 |
| JP2014524435A (ja) | 2014-09-22 |
| AU2012296266A1 (en) | 2014-03-13 |
| EP2744506B1 (en) | 2019-10-09 |
| EP2744506A4 (en) | 2015-06-03 |
| CN103889438B (zh) | 2016-08-24 |
| CA2845617A1 (en) | 2013-02-21 |
| JP6222779B2 (ja) | 2017-11-01 |
| US9783574B2 (en) | 2017-10-10 |
| US20130072431A1 (en) | 2013-03-21 |
| CN103889438A (zh) | 2014-06-25 |
| SG11201400067TA (en) | 2014-04-28 |
| WO2013024362A3 (en) | 2013-07-25 |
| AU2012296266B2 (en) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2507211B (en) | Trampoline | |
| DK3798230T3 (en) | Terapeutiske antistoffer | |
| IL234056A0 (en) | Erythrocyte binding therapies | |
| ZA201309278B (en) | Trampolines | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| SI2525128T1 (sl) | Prehodni kos | |
| GB2535351B (en) | Trampoline | |
| GB201119167D0 (en) | Novel bachteriophages | |
| IL227377A0 (en) | Combinations | |
| SG11201400067TA (en) | Cardiovascular therapeutics | |
| GB201108220D0 (en) | Bungee spongee | |
| GB201113923D0 (en) | Novel combinations | |
| GB201108290D0 (en) | Solid supports | |
| GB201116426D0 (en) | Novel saccharide based therapeutics | |
| GB201107854D0 (en) | Novel 5-hydroxy-5-aryl-pyrrol-2-ones | |
| GB201113987D0 (en) | Discretion | |
| GB201109019D0 (en) | Condensafe | |
| GB201100008D0 (en) | Jigsawing | |
| GB201100055D0 (en) | Evac-sac | |
| GB201100364D0 (en) | Aimspray | |
| GB201101143D0 (en) | Post-reference | |
| GB201101931D0 (en) | Kerbknight | |
| GB201102519D0 (en) | Mirrorcane | |
| GB201102755D0 (en) | Protectaridge | |
| GB201102977D0 (en) | Cyclobuggy |